Last reviewed · How we verify

NCT04885699

Validation of Capnodynamic Assessment of Mixed Venous Oxygen Saturation

Completed Last updated 16 January 2025
What this trial tests

trial in Cardiac Output, Low in 29 participants. Completed in 1 October 2023.

Timeline
1 June 2021
Primary endpoint
1 June 2023
1 October 2023

Quick facts

Lead sponsorKarolinska Institutet
StatusCompleted
Study typeOBSERVATIONAL
Enrollment29
Start date1 June 2021
Primary completion1 June 2023
Estimated completion1 October 2023
Sites1 location across Sweden

Conditions studied

Sponsor

Karolinska Institutet

Who can join

Adults 0 to 18, any sex, with Cardiac Output, Low or Cardiac Output, High. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Mixed venous saturation (SvO2) is an indicator of the balance between oxygen supply and demand in the body's tissues Recently, our research team published a paper describing the possibility to continuously monitor SvO2 by the use of continuous dynamic capnography (Karlsson et al, A Continuous Noninvasive Method to Assess Mixed Venous Oxygen Saturation: A Proof-of-Concept Study in Pigs. Anesth Analg 2020) The primary objective of the current study is thus to investigate the agreement and trending ability for capnodynamically derived SvO2 against the gold standard CO-oximetry. The secondary objective is to investigate the agreement and trending ability for capnodynamically derived CO (COEPBF) against the modified CO2-Fick method.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cardiac Output, Low

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04885699.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing